ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
6
views
0
references
Top references
cited by
7
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
2
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,043
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Covid-19: Remdesivir probably reduces recovery time, but evidence is uncertain, panel finds
Author(s):
Elisabeth Mahase
Publication date
(Electronic):
July 30 2020
Journal:
BMJ
Publisher:
BMJ
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free pdf)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Novel Coronavirus Disease COVID-19
Author and article information
Journal
Title:
BMJ
Abbreviated Title:
BMJ
Publisher:
BMJ
ISSN (Electronic):
1756-1833
Publication date (Electronic):
July 30 2020
Page
: m3049
Article
DOI:
10.1136/bmj.m3049
PubMed ID:
32732277
SO-VID:
c89cd354-2c60-4388-9ae5-5edff99d3587
Copyright ©
© 2020
License:
Free to read
https://bmj.com/coronavirus/usage
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,043
Covid-19: EU countries spent over €220m stockpiling remdesivir despite lack of effectiveness, finds investigation
Authors:
Lucien Hordijk
,
Priti Patnaik
Gilead announces approval of Veklury® (remdesivir) in Japan for patients with severe COVID-19
Authors:
Gilead
Approval of Veklury (remdesivir) for the Treatment of COVID-19—The Science of Safety and Effectiveness
Authors:
See all similar
Cited by
7
Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database
Authors:
Alexandre O. Gérard
,
Audrey Laurain
,
Audrey Fresse
…
Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19
Authors:
Tianchuan Zhu
,
Yuchen Xiao
,
Xiaojun Meng
…
A pandemic of cognitive bias
Authors:
Francesco Landucci
,
Massimo Lamperti
See all cited by
Version 1
- Current
Version 1